Table 2.
Intra-patient CV (%) for LNSC at baseline and over all time points.
| n | Baseline | All time points | |
|---|---|---|---|
| Baseline mLNSC × ULN | |||
| ≤1.5 | 73 | 45.6 | 51.5 |
| 1.5–2.0 | 28 | 46.1 | 44.9 |
| 2.5–5.0 | 17 | 42.0 | 49.0 |
| 5.0–10.0 | 3 | 44.2 | 53.2 |
| Age, years | |||
| <60 | 113 | 44.9 | 49.7 |
| ≥60 | 8 | 48.5 | 45.9 |
| Sex | |||
| Female | 94 | 43.6 | 49.4 |
| Male | 27 | 50.4 | 49.5 |
| Baseline diabetic status | |||
| Diabetic | 48 | 41.0 | 48.2 |
| Pre-diabetic | 17 | 44.4 | 49.3 |
| Non-diabetic | 56 | 48.7 | 50.5 |
| Baseline hypertensive status | |||
| Hypertensive | 84 | 42.6 | 48.4 |
| Pre-hypertensive | 24 | 35.9 | 48.4 |
| Normotensive | 13 | 70.0 | 57.9 |
The two LNSC samples were taken within the same 24-h period as the first two of three UFC samples.
This work is licensed under a